People

Renee joined Samsung Ventures in 2025. Prior to joining the firm, she worked at Connecticut Innovations, the strategic venture capital arm for the state of Connecticut, where she invested across multiple life science verticals including therapeutics, R&D tools, digital health, and AgTech. During her tenure, she participated in several notable transactions, including the acquisitions of Modifi Bio by Merck and Halda Therapeutics by Johnson & Johnson. Renee earned her Ph.D. in Molecular, Cellular, and Developmental Biology from Yale University and her B.S. in Molecular and Cellular Biology from the University of Connecticut.